Vijaya Diagnostic Centre DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.75×	0.74×	0.74×	0.75×	0.75×
	0.95×	0.95×	0.95×	0.97×	0.94×
	31.0%	30.1%	29.7%	29.9%	26.2%
	0.59×	0.59×	0.60×	0.60×	0.59×
	1.57×	1.57×	1.59×	1.49×	1.56×
	20.3%	19.7%	20.2%	19.5%	17.1%
	19.7%	19.7%	19.7%	19.8%	16.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

VIJAYA₹1,400.00

Vijaya Diagnostic Centre Ltd.

· Pharma & Health

₹ CrorePeersTHYROCARE METROPOLIS LALPATHLAB RAINBOW POLYMED PFIZER ONESOURCE KIMSMcap ₹14,406 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.75	0.75	0.74	0.74	0.75
Interest Burden (Pretax/EBIT) ×	0.94	0.97	0.95	0.95	0.95
EBIT Margin %	26.20	29.92	29.74	30.10	31.02
Asset Turnover ×	0.59	0.60	0.60	0.59	0.59
Financial Leverage (Assets/Equity) ×	1.56	1.49	1.59	1.57	1.57
ROE (5-step product, year-end total equity) %	17.09	19.51	20.18	19.74	20.32
ROE (owners' profit / average owners' equity) %	16.71	19.77	19.70	19.74	19.74

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.